Pharmaceutical manufacturing

Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More
April 03, 2019 - 5:50 pm
LITTLE ROCK, Ark. (AP) — Arkansas lawmakers have sent the governor legislation expanding the secrecy surrounding the source of the state's lethal injection drugs, over the objections of press groups, pharmaceutical companies and death penalty opponents. The House voted 71-16 on Wednesday for a bill...
Read More
Vaccine
Dreamstime
March 22, 2019 - 7:42 am
WALTON, Ky. (AP) — An unvaccinated student in Kentucky will get his day in court after suing because he can't participate in extracurricular activities during a chickenpox outbreak. The Courier Journal reports 18-year-old Jerome Kunkel's case will be heard in court April 1. Unvaccinated students...
Read More
March 19, 2019 - 7:06 pm
TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics' Zulresso, an IV drug given over 2 ½ days. Sage said Zulresso will cost $34,000 without insurance,...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 9:54 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad warns that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of the Alliance for Patient Access, a...
Read More
March 12, 2019 - 6:58 am
MINNETONKA, Minn. (AP) — The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, all employer-sponsored health care plans that use UnitedHealthcare must give point-of-sale discounts...
Read More
FILE- This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial. (AP Photo/Darron Cummings, File)
March 04, 2019 - 2:32 pm
INDIANAPOLIS (AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain imposed on some patients, but an advocacy group says much bigger changes are needed. The drugmaker said Monday it will introduce a version of the diabetes treatment Humalog that will...
Read More
February 27, 2019 - 4:57 am
COPENHAGEN, Denmark (AP) — Volatility in stock markets last year pushed Norway's sovereign wealth fund, the world's largest of its kind, to report a loss of 485 billion kroner ($56.4 billion) for 2018. Fund manager Norges Bank Investment Management says the fund's worst-performing investments in...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:42 pm
WASHINGTON (AP) — Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday's Senate...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:41 pm
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 1:30 Senators are urging top pharmaceutical executives to help Congress take action against the industry's worst actors who hike prices on once-cheap drugs...
Read More

Pages